Business Description
Kabra Drugs Ltd
ISIN : INE323K01017
Compare
Compare
Traded in other countries / regions
524322.India IPO Date
1993-08-16Description
Kabra Drugs Ltd is an India-based drug manufacturing company. It is engaged in the manufacturing and sale of ether derivatives and pharmaceutical formulations. Geographically, all the company operations are carried out in India. It generates revenue from the sale of materials principally in India. The company plant for manufacturing the drugs is located in the Indian state of Madhya Pradesh. Its products include Cardiovascular Drugs, Anti-Infective Drugs, Oncology Drugs, Gastroenterologic Drugs, Hormonal Drugs, etc.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | N/A |
N/A
|
N/A
| |||
| Debt-to-Equity | N/A |
N/A
|
N/A
| |||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -131.6 | |||||
| 3-Year EPS without NRI Growth Rate | -78.2 | |||||
| 3-Year FCF Growth Rate | -97.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 83.25 | |||||
| 9-Day RSI | 62.79 | |||||
| 14-Day RSI | 50.23 | |||||
| 6-1 Month Momentum % | -25.49 | |||||
| 12-1 Month Momentum % | -19.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -6.9 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -53.59 | |||||
| ROIC % | -32.6 | |||||
| ROC (Joel Greenblatt) % | -66.27 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -7.49 | |||||
| EV-to-EBITDA | -7.49 | |||||
| EV-to-FCF | -7.58 | |||||
| Earnings Yield (Greenblatt) % | -13.36 | |||||
| Forward Rate of Return (Yacktman) % | -2.43 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kabra Drugs Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | |||
| EPS (TTM) (₹) | -0.88 | ||
| Beta | 0.5 | ||
| Volatility % | 40.75 | ||
| 14-Day RSI | 50.23 | ||
| 14-Day ATR (₹) | 0.115874 | ||
| 20-Day SMA (₹) | 3.5905 | ||
| 12-1 Month Momentum % | -19.57 | ||
| 52-Week Range (₹) | 3.18 - 5.91 | ||
| Shares Outstanding (Mil) | 4.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kabra Drugs Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kabra Drugs Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kabra Drugs Ltd Frequently Asked Questions
What is Kabra Drugs Ltd(BOM:524322)'s stock price today?
The current price of BOM:524322 is ₹3.87. The 52 week high of BOM:524322 is ₹5.91 and 52 week low is ₹3.18.
When is next earnings date of Kabra Drugs Ltd(BOM:524322)?
The next earnings date of Kabra Drugs Ltd(BOM:524322) is .
Does Kabra Drugs Ltd(BOM:524322) pay dividends? If so, how much?
Kabra Drugs Ltd(BOM:524322) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers